The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

Valérie A.M. Meijvis; Mette Heringa; Henk Frans Kwint; Niek J. de Wit; Marcel L. Bouvy

doi:10.1016/j.sapharm.2023.04.118

The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

Valérie A.M. Meijvis^*
, Mette Heringa
, Henk Frans Kwint
, Niek J. de Wit
, Marcel L. Bouvy

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.

Original language	English
Pages (from-to)	1054-1060
Number of pages	7
Journal	Research in Social and Administrative Pharmacy
Volume	19
Issue number	7
DOIs	https://doi.org/10.1016/j.sapharm.2023.04.118
Publication status	Published - Jul 2023

Bibliographical note

Funding Information:
This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation.

Funding Information:
This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation.

Publisher Copyright:
© 2023 The Authors

Funding

This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation. This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CombiConsultation
Community pharmacist
General practice
Pharmaceutical care
Primary care

Access to Document

10.1016/j.sapharm.2023.04.118Licence: CC BY

1-s2.0-S1551741123002334-mainFinal published version, 783 KBLicence: CC BY

Cite this

@article{88d6bade1e3943c7b9795ae9cbf6506c,

title = "The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals",

abstract = "Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49\% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33\%), undertreatment (18\%) and overtreatment (14\%). In 71\% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72\% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53\% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.",

keywords = "CombiConsultation, Community pharmacist, General practice, Pharmaceutical care, Primary care",

author = "Meijvis, \{Val{\'e}rie A.M.\} and Mette Heringa and Kwint, \{Henk Frans\} and \{de Wit\}, \{Niek J.\} and Bouvy, \{Marcel L.\}",

note = "Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation. Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation. Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = jul,

doi = "10.1016/j.sapharm.2023.04.118",

language = "English",

volume = "19",

pages = "1054--1060",

journal = "Research in Social and Administrative Pharmacy",

issn = "1551-7411",

publisher = "Elsevier Inc.",

number = "7",

}

The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals. / Meijvis, Valérie A.M.; Heringa, Mette; Kwint, Henk Frans et al.
In: Research in Social and Administrative Pharmacy, Vol. 19, No. 7, 07.2023, p. 1054-1060.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases

T2 - Evaluation of interventions and personal health-related goals

AU - Meijvis, Valérie A.M.

AU - Heringa, Mette

AU - Kwint, Henk Frans

AU - de Wit, Niek J.

AU - Bouvy, Marcel L.

N1 - Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation. Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation. Publisher Copyright: © 2023 The Authors

PY - 2023/7

Y1 - 2023/7

N2 - Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.

AB - Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.

KW - CombiConsultation

KW - Community pharmacist

KW - General practice

KW - Pharmaceutical care

KW - Primary care

UR - https://www.scopus.com/pages/publications/85153289863

U2 - 10.1016/j.sapharm.2023.04.118

DO - 10.1016/j.sapharm.2023.04.118

M3 - Article

AN - SCOPUS:85153289863

SN - 1551-7411

VL - 19

SP - 1054

EP - 1060

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

IS - 7

ER -

The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

Abstract

Bibliographical note

Funding

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this